SP 23
The ASFA therapeutic apheresis guidelines – 8th edition – overview with focus on hematology/oncology indications
Nancy M. Dunbar
Lido
10584
Vezesque se leu este artigo
4113
Total PDF
6471
Total HTML
| Ano/Mês | Html | Total | |
|---|---|---|---|
| 2025 7 | 19 | 7 | 26 |
| 2025 6 | 134 | 48 | 182 |
| 2025 5 | 138 | 42 | 180 |
| 2025 4 | 114 | 32 | 146 |
| 2025 3 | 139 | 36 | 175 |
| 2025 2 | 107 | 51 | 158 |
| 2025 1 | 140 | 40 | 180 |
| 2024 12 | 70 | 41 | 111 |
| 2024 11 | 70 | 41 | 111 |
| 2024 10 | 56 | 39 | 95 |
| 2024 9 | 83 | 38 | 121 |
| 2024 8 | 85 | 54 | 139 |
| 2024 7 | 72 | 37 | 109 |
| 2024 6 | 87 | 51 | 138 |
| 2024 5 | 75 | 50 | 125 |
| 2024 4 | 108 | 62 | 170 |
| 2024 3 | 107 | 59 | 166 |
| 2024 2 | 96 | 61 | 157 |
| 2024 1 | 86 | 60 | 146 |
| 2023 12 | 97 | 78 | 175 |
| 2023 11 | 157 | 79 | 236 |
| 2023 10 | 159 | 99 | 258 |
| 2023 9 | 170 | 105 | 275 |
| 2023 8 | 170 | 59 | 229 |
| 2023 7 | 106 | 60 | 166 |
| 2023 6 | 115 | 62 | 177 |
| 2023 5 | 150 | 64 | 214 |
| 2023 4 | 95 | 43 | 138 |
| 2023 3 | 133 | 111 | 244 |
| 2023 2 | 112 | 73 | 185 |
| 2023 1 | 128 | 71 | 199 |
| 2022 12 | 105 | 83 | 188 |
| 2022 11 | 129 | 93 | 222 |
| 2022 10 | 172 | 128 | 300 |
| 2022 9 | 136 | 117 | 253 |
| 2022 8 | 148 | 100 | 248 |
| 2022 7 | 123 | 107 | 230 |
| 2022 6 | 124 | 79 | 203 |
| 2022 5 | 124 | 84 | 208 |
| 2022 4 | 119 | 72 | 191 |
| 2022 3 | 93 | 67 | 160 |
| 2022 2 | 114 | 74 | 188 |
| 2021 1 | 122 | 86 | 208 |
| 2021 12 | 123 | 107 | 230 |
| 2021 11 | 127 | 109 | 236 |
| 2021 10 | 135 | 103 | 238 |
| 2021 9 | 122 | 104 | 226 |
| 2021 8 | 104 | 84 | 188 |
| 2021 7 | 124 | 104 | 228 |
| 2021 6 | 108 | 102 | 210 |
| 2021 5 | 136 | 114 | 250 |
| 2021 4 | 286 | 188 | 474 |
| 2021 3 | 163 | 100 | 263 |
| 2021 2 | 63 | 69 | 132 |
| 2020 1 | 60 | 47 | 107 |
| 2020 12 | 25 | 24 | 49 |
| 2020 11 | 8 | 15 | 23 |
Mostrar tudo
